News Updates - Voyageur Pharmaceuticals

NEWS

October 2, 2026

Voyageur Pharmaceuticals Announces Completion of Shares for Debt Settlement

Calgary, Alberta–(Newsfile Corp. – October 2, 2026) – Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) (“Voyageur” or...

September 24, 2026

Voyageur Pharmaceuticals Announces Proposed Issuance of Shares for Debt

Calgary, Alberta–(Newsfile Corp. – September 24, 2026) – Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) (“Voyageur” or...

September 10, 2026

(PODCAST) Voyageur Pharmaceuticals (TSXV:VM) Achieves First Milestone in Bayer Collaboration, Secures USD $1 Million Payment

CALGARY, Alberta — September 10, 2026 — Leads & Copy — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC Pink:...

September 8, 2026

Voyageur Pharmaceuticals Achieves First Milestone on Feasibility Study for Iodine Production; Secures USD $1 Million Payment

CALGARY, Alberta – September 8, 2026 – Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC Pink: VYYRF) (“Voyageur” or the...

Voyageur Pharmaceuticals Announces the Engagement of Red Cloud Securities as Market Maker

FOR IMMEDIATE RELEASE CALGARY, Alberta – July 17, 2026 – Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC Pink: VYYRF)...

Voyageur Pharmaceuticals Engages Fluor to Advance Feasibility Studies for Iodine Production and Integrated Contrast Drug Manufacturing Facility

FOR IMMEDIATE RELEASE CALGARY, Alberta – June 23, 2026 – Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC Pink: VYYRF)...

12 3…9

Next ›

¹ SGS PEA
^1.1 SGS PEA Item 1.17 (p. 16) and Table 21-6 (p. 174); USP assay Table 1-2 (p. 10–11).
² Global contrast media market projected to reach $13.9B by 2033, at a CAGR of 8.4%. Source: Grand View Research, “Contrast Media Market Size And Share Report, 2026-2033.”